Announcements Trials
Browse Landscape

Status

Completed 2Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Observational 5Interventional 2

Sponsor

Cancer Type

Plasma cell 2Sarcoma 1Lymphoid 1Head & Neck 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Multiple Myeloma 2Sarcoma 1Osteosarcoma 1Neoplasms, Plasma Cell 1Mobility Limitation 1Melanoma 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Kidney Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Transitional Cell 1COVID-19 1Breast Neoplasms 1

Interventions

Blood Specimen Collection 53Surveys and Questionnaires 49Specimen Handling 29Observation 15Radiotherapy 14Magnetic Resonance Spectroscopy 12Surgical Procedures, Operative 11Interviews as Topic 11Data Collection 11Drug Therapy 9darolutamide 8Biopsy 8palbociclib 7Watchful Waiting 7Tomography, X-Ray Computed 7Standard of Care 7ribociclib 6Magnetic Resonance Imaging 6Bevacizumab 6trastuzumab deruxtecan 5Ultrasonography 5Restraint, Physical 5Radiofrequency Ablation 5Patient Reported Outcome Measures 5Mental Status and Dementia Tests 5Mastectomy, Segmental 5Mass Screening 5Genetic Testing 5Breath Tests 5enzalutamide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Observational × Patient Reported Outcome Measures × 90 days × Clear all
NCT07502885 2026-06-04

Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer Patients

St. Jude Children's Research Hospital

Recruiting
300 enrolled
Sarcoma

Sarcoma, Osteosarcoma, Mobility Limitation

NCT04769960 2026-05-18

Study of the Safety of MRI Scans in People Who Have Breast Tissue Expanders After Mastectomy

Memorial Sloan Kettering Cancer Center

Active not recruiting
68 enrolled
Breast

Breast Neoplasms

NCT05831787 2026-05-18

COSMIC

ASH Research Collaborative

Completed
201 enrolled 15 charts
Plasma cell

COVID-19, Multiple Myeloma, Neoplasms, Plasma Cell

NCT04146064 2026-05-08

Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response

University Health Network, Toronto

Completed
190 enrolled
DermatologicGenitourinaryHead & Neck

Carcinoma, Transitional Cell, Head and Neck Neoplasms, Kidney Neoplasms, Melanoma

NCT07558057 2026-04-30

COGNITOX

University of Aarhus

Not yet recruiting
225 enrolled
LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡